Dr. Mohd Khairi bin Ismail is a respected Malaysian economist, researcher, and academic who currently serves as a Senior Lecturer at the Faculty of Business and Management, Universiti Teknologi MARA (UiTM) Cawangan Terengganu. With over 15 years of experience in higher education and research, Dr. Khairi has made significant contributions in the fields of development economics, environmental economics, and poverty studies. He is also a Postdoctoral Research Fellow at the Ungku Aziz Centre for Development Studies (UAC), University of Malaya—an institution known for championing inclusive and sustainable development research. A First-Class Honours graduate in Economics from Universiti Utara Malaysia (UUM), Dr. Khairi later earned his PhD in Environment and Development (Economics) from Universiti Kebangsaan Malaysia (UKM). His academic journey reflects a deep commitment to interdisciplinary research addressing socio-economic issues affecting the B40 community, urban poverty, and sustainable livelihoods. His scholarly work has been published in more than 60 journals, proceedings, and book chapters, with multiple publications indexed in Scopus and Web of Science (WoS).  Dr. Khairi has received numerous recognitions and academic awards, including the best paper award and multiple gold medals for innovation in research and teaching. His policy-based research has received grants from national research bodies, especially in projects related to community well-being, Islamic social finance, and urban resilience. In addition, he is an editorial board member for SAGE Open and reviewer for several national and international journals. His expertise has also earned him frequent invitations to media appearances, both in print and broadcast. Dr. Khairi has been featured on RTM and RTM Radio, offering expert commentary on national issues such as the cost of living, national budget, SST vs GST, and inflation. He has also contributed opinion pieces and interviews to major newspapers including Berita Harian, Utusan Malaysia, Sinar Harian, and The Star. His media engagements are characterized by a balanced, data-driven, and policy-relevant approach that bridges the gap between academia and the public.

Dr. Kamarul Ariffin Noordin is a distinguished academic and researcher in the field of wireless communications, with a decade-long focus on advancing communication technologies through impactful research and international collaborations. Since 2014, he has served as principal or co-principal investigator for competitive research grants totaling over RM1.4 million from esteemed bodies such as the Ministry of Science, Technology, and Innovation (MOSTI), the Ministry of Higher Education Malaysia, the EPSRC UK, and UAE University. He is currently a Professor at the Department of Electrical Engineering, University of Malaya. His research has spanned a range of groundbreaking topics, including seamless mobile communication in heterogeneous networks, device-to-device communications for disaster management, and dynamic resource allocation using AI and UAVs for future 5G/6G networks. A notable highlight was his role in a three-year Global Challenges Research Fund project with the University of Surrey and other UK institutions, where he led efforts to develop emergency communication strategies in disaster zones. Dr. Kamarul has published over 70 papers in reputable ISI-indexed journals and conferences. His collaborative works include research with scholars from Vietnam, the UK, Norway, Greece, and the UAE, with contributions to emerging topics such as NOMA, SWIPT, and AI-driven wireless systems. His growing international visibility has led to increasing PhD supervision requests and global research partnerships.

Dr. Mohd Danish Ansari is an academician and researcher specializing in pharmaceutics, pharmaceutical nanotechnology, and advanced drug delivery systems. He currently serves as a lecturer at the Dept. of Pharmaceutical Technology, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia. His teaching portfolio spans pharmaceutical engineering, industrial pharmacy, novel drug delivery systems, pharmaceutical analysis, regulatory affairs, and dosage form design at both undergraduate and postgraduate levels. He also holds several academic leadership roles, including Course Coordinator (Quality Assurance), Head of the Certification Unit, member of the Universiti Malaya Research Ethics Committee (UMREC), Accreditation Task Force member, and Final Year Project (FYP) Coordinator. He actively contributes as a postgraduate thesis evaluator, PhD examiner, and academic administrator. Dr. Ansari earned his Ph.D. in Pharmaceutics from Jamia Hamdard, where his doctoral research focused on the development of novel vesicular spanlastic systems for enhancing the bioavailability of BCS Class II drugs via the transdermal route. He also completed his M.Pharm, B.Pharm, and D.Pharm from the same institution. His research interests include pharmaceutical nanotechnology, transdermal and targeted drug delivery, biomaterials, hydrogels, lipid and polymeric nanoparticles, nanomedicine, pharmacokinetics and pharmacodynamics, and regulatory sciences. In addition to academia, Dr. Ansari has professional experience as an associate scientific writer at leading life sciences consulting organizations, where he contributed to manuscript preparation, regulatory writing, medical information development, instructional design, data analytics, and scientific communications. Earlier in his career, he served as a lecturer in pharmaceutics and worked as a project assistant under a DST Nano Mission-funded project of the government of India, focusing on the formulation and in vivo evaluation of nanoemulsion-based drug delivery systems for osteoporosis management. Dr. Ansari is a GPAT-qualified professional and recipient of multiple Best Publication Awards for high-impact research contributions. His scholarly work reflects a strong commitment to innovation in nanomedicine and translational pharmaceutical research. Dr. Ansari has authored over 25 high-impact publications in Q1–Q3 journals, including pioneering work on nanospanlastics, lipid-polymer hybrid nanoparticles, SNEDDS, and nanoengineered delivery systems for neurological disorders, osteoporosis, and cancer. He has contributed book chapters on nanostructured drug carriers and fixed-dose combination techniques. His research has been recognized internationally, and he has presented at multiple conferences, receiving awards for oral presentations. His publications demonstrate a strong translational focus, bridging innovative nanotechnology with patient-centered therapeutic applications. Dr. Ansari serves as a peer reviewer for several national and international journals. His expertise in pharmaceutics, nanotechnology, and drug delivery enables him to critically evaluate manuscripts and contribute to maintaining high scientific standards in these publications.